Synonym:
4-[2-(Dipropylamino)ethyl]-1,3-dihydro-2H-indol-2-one hydrochloride,
Ropinirole hydrochloride,
SKF 101468 hydrochloride
Properties:
| Related Categories |
Additional Standards,
Analytical Standards,
Analytical/Chromatography,
Chromatography,
Pharmaceutical Secondary Standards,
|
|
grade
|
certified reference material
|
|
|
pharmaceutical secondary standard
|
|
InChI Key
|
XDXHAEQXIBQUEZ-UHFFFAOYSA-N
|
|
packaging
|
pkg of 200 mg
|
|
pharmacopeia traceability
|
traceable to PhEur Y0001773
|
|
|
traceable to USP 1605205
|
Description:
Analysis Note
These secondary standards offer multi-traceability to the USP, EP and BP primary standards, where they are available.
General description
Pharmaceutical secondary standards for application in quality control provide pharma laboratories and manufacturers with a convenient and cost-effective alternative to the preparation of in-house working standards
Other Notes
This product was designed, produced and verified for accuracy and stability in accordance with ISO/IEC 17025:2005 (AClass Cert AT-1467), ISO GUIDES 34:2009 (AClass Cert AR-1470).
Biochem/physiol Actions
An agonist at the D2 and D3 dopamine receptor subtypes, binding with higher affinity to D3 than to D2 or D4. It has negligible effect on D1-receptors. It has medium in vitro affinity to opioid receptors. Ropinirole is said to have virtually no affinity to 5-HT1, 5-HT2, benzodiazepine, GABA, muscarinic, α1-, α2-, and β-adrenoreceptors. Used as antiparkinsonian drug.
Footnote
To see an example of a Certificate of Analysis for this material enter LRAA5300 in the Documents slot below. This is an example certificate only and may not be the lot that you receive.
Safety:
Symbol


GHS07, GHS09
Hazard statements
H302-H400
Precautionary statements
P273